EACR 2026 (the European Association for Cancer Research)brought the cancer research community together in Budapest from 8–11 June for four days of science, innovation, and collaboration.
The Annual Congress of the European Association for Cancer Research highlighted the latest advances in basic, preclinical, and translational cancer research, covering a wide range of topics that reflect the rapidly evolving landscape of cancer science.
As a global scientific community dedicated to advancing cancer research, EACR once again created a platform for researchers to share knowledge, build connections, and inspire new collaborations that may shape the future of cancer discovery and treatment.
“Awesome symposium presenting results from Hungarian cancer research at the European Association for Cancer Research (EACR) 2026.
Chaired by Attila Patocs and József Tóvári, presenters discussed results regarding the roles of selenoproteins and redox biology in cancer by Beáta Biri-Kovács, transsulfuration in pancreatic cancer by Agnes Czikora, glucocorticoid receptor signaling in breast cancer by Henriett Butz, epigenetic mechanisms driving therapy resistance by Sandor Spisak, and CAR T cell therapies in solid tumors by Arpad Szoor.
Congratulations!”
“The wonderful Johanna Joyce opened the session on the tumor microenvironment with exciting new insights on the TME in brain metastasis at the European Association for Cancer Research (EACR).”
“Honoured and excited to have presented our research at the European Association for Cancer Research (EACR) 2026 Congress in Budapest as part of the Award Winners Special Session.
I am grateful to The Mark Foundation for Cancer Research and EACR for their support through the Postdoctoral Fellowship, and for the opportunity to share our work on unlocking CD8+ T cell anti-tumour activity in brain metastasis.
Brain metastases remain a major clinical challenge, and I am excited to discuss our efforts to better understand and overcome T cell dysfunction in this context.
A big thank you to all the colleagues and collaborators who have contributed to this first year of work. Special thanks to Prof. Johanna Joyce and the entire team for creating an environment where ambitious science can thrive.
Looking forward to a week of inspiring science, new ideas, and stimulating discussions. If you are attending EACR 2026, I would be delighted to connect!”
“We are really enjoying the EACR 2026 Congress, and many Joyce Lab members are here in force.
Presenting lots of new unpublished data — from Julie’s talk yesterday on the T cell ecosystem in brain metastases, to mine today sharing our latest findings on the complexity of cancer ecosystems. It is a privilege, as always, to present the research of the wonderful scientists in my group.
Still lots more unpublished data to come from our posters today and tomorrow for anyone who would like to stop by:
Caroline Wandinger — Poster 011
Benoit Duc — Poster 571
Rui Santalla Méndez — Poster 706
Alessandro Matera — Poster 668
Paola Guerrero Aruffo — Poster 672”
European Association for Cancer Research (EACR):
“We’re delighted to have awarded 52 Travel Grants to help researchers from 26 countries attend EACR 2026.
Congratulations to all of you!”
“Day 2 at the European Association for Cancer Research (EACR) Congress in Budapest.
Our Director of Research, Dr. Ian Lewis, is joining a panel discussion on the grant-making process. If you would like to learn more about funding opportunities from Worldwide Cancer Research, come see us in the main hall.”
“Day 3 at the European Association for Cancer Research (EACR) Congress in Budapest.
More great talks and workshops to enjoy, and I am looking forward to hosting a round table on research funding this afternoon.
If anyone has any questions, please drop by the Worldwide Cancer Research exhibition in the main hall.”
“Thank you to everyone who attended my talk at the Annual Congress of the European Association for Cancer Research (EACR) during the Oxford Nanopore Technologies Industry Symposium.
I shared our work on nanopore-enabled RNA liquid biopsy and how long-read sequencing of cell-free RNA from blood can expand liquid biopsy beyond detection toward biological intelligence and interpretation.
Thank you to Eleonora Juarez, PhD, Sally Evans, and the Oxford Nanopore Technologies team for organizing.
If you are at EACR 2026 and would like to connect, please feel free to DM or email me at daniel.kim@ucsc.edu.”
“Had the privilege of presenting my work at EACR 2026 in Budapest.
Huge thanks to the European Association for Cancer Research (EACR) organizing committee for the invitation, to Arkaitz Carracedo for chairing a great session, and to the CRIS Cancer Foundation, Prostate Cancer Foundation, Ian Mills, the Nuffield Department of Surgical Sciences at the University of Oxford, all our collaborators, and, crucially, the patients involved for supporting this research.
I was particularly happy to present work supported by brilliant early-career researchers Tanya Bell, Thineskrishna Anbarasan, Ellie MacLeod, Sophia Abusamra, and Imogen Bridges.
Looking forward to more days of exciting science!”
IARC – International Agency for Research on Cancer / World Health Organization:
“IARC Director Dr. Elisabete Weiderpass spoke at the European Association for Cancer Research (EACR) Annual Congress in Budapest, Hungary, during a session on cancer prevention.
Her talk focused on evidence-based strategies that can prevent a substantial share of cancer incidence.”
“Over 2,400 people working and studying in cancer research joined us this week for EACR 2026 — and what a success it has been.
We covered the latest science across a wide range of fields, presented cutting-edge technologies and the companies behind them, and helped scientists from around the world connect.
If you were there and met someone you plan to establish a working relationship with, don’t forget about our Collaboration Fellowships. Open until 03 September, these grants can help fund research visits to each other’s labs.
Find out more: https://bit.ly/4xrnPVu”
“Thrilled to present the latest data from our MyoTumour project at the European Association for Cancer Research (EACR) 2026 in Budapest.
Funded by the European Commission under the Marie Skłodowska-Curie Actions, this project aims to push the boundaries of cancer research.
Connecting with scientists from around the world and diving into groundbreaking research has been incredibly rewarding.Looking forward to bringing these insights back to the lab.”
European Association for Cancer Research (EACR):
“As EACR 2026 closes, we are thrilled to welcome Professor Johanna Joyce as our new EACR President.
Johanna is an award-winning researcher specializing in the tumour microenvironment at the University of Lausanne, Switzerland, and the Ludwig Institute for Cancer Research.
We are looking forward to the next two years together!”
“As the EACR Congress has come to a close here in Budapest, I officially begin my term as President of the European Association for Cancer Research.
It has been an energising week, with so much unpublished data, lively discussions, inspiring science, and an equally inspiring community.
The EACR has been an important scientific home for me for many years. It brings together an extraordinary community of cancer researchers across Europe and beyond, united by curiosity, ambition, collegiality, and a shared belief in the power of discovery to change the lives of patients.
I am so excited to work with the EACR Board, the entire EACR team, and our wider community to build on the strong foundation shaped by outstanding EACR Presidents over the years and strengthened by the wonderful Yardena Samuels during her presidency. It has been a pleasure to serve with her.
Over the next two years, I am committed to supporting excellent science, creating opportunities for the next generations, strengthening connections across countries and disciplines, and ensuring that cancer research in Europe remains bold, collaborative, and internationally leading.
At a time when science faces many pressures, what we have built together matters more than ever. We need spaces where researchers can come together, exchange ideas openly, support one another, and imagine all that is possible.
Thank you to everyone who made this congress such a success, and to all those who make the EACR such a vibrant and welcoming home for cancer research.
I am honoured to serve as your President and excited for the journey ahead.”
European Association for Cancer Research (EACR):
“It’s hard to believe EACR 2026 is almost over.
Huge thanks from the EACR Congress team to everyone who made it so special.
And to those following our posts from home, we hope to welcome you in person next year!”
“And that’s a wrap on a phenomenal four days at the EACR 2026 Congress in Budapest.
Proud to have spent the week representing the MRC Laboratory of Medical Sciences (LMS) alongside three brilliant colleagues. From incredible keynotes to engaging scientific discussions, it has been an inspiring and motivating few days.
All four of us were thrilled to present our research posters this week. The feedback, thought-provoking questions, and insights we received from fellow cancer researchers made the experience incredibly rewarding.
A huge thank you to the European Association for Cancer Research (EACR) for hosting such a fantastic event, and to everyone who stopped by our posters to chat science.
We are heading back to the lab with fresh ideas and renewed energy for the next steps in our research.”
“It was an awesome moment to present my work during the Poster Spotlight event at EACR 2026.
Thank you for the invitation, and I am already looking forward to next year’s conference of the European Association for Cancer Research (EACR).”
“Grateful to have attended this year’s European Association for Cancer Research (EACR) Conference in beautiful Budapest, where I had the opportunity to share my work on the role of platelets in kidney cancer metastasis.
A huge thank you to the organizers, speakers, and everyone who shared their work and enthusiasm.
I am leaving Budapest with new ideas, new connections, and renewed motivation for the next year of my PhD.
Hamarosan találkozunk Budapesten.”
“Great to be back at EACR in 2026.
Excited to present our work, exchange ideas with this outstanding community of scientists, foster new collaborations, and enjoy the beautiful city of Budapest.
I had the chance to speak about a topic that is close to my heart: immune checkpoint inhibitor-induced toxicities, and how we can better predict, understand, and ultimately prevent these treatment-limiting side effects for our patients.
Looking forward to inspiring discussions, fresh perspectives, and building connections that drive translational cancer research forward.”
“I had the pleasure of attending the European Association for Cancer Research (EACR) Congress this year, and it was truly an outstanding experience.
The scientific quality of the conference was exceptional, with inspiring talks from leading researchers and countless opportunities for stimulating discussions and new collaborations. It was fascinating to learn about the latest advances in cancer research and exchange ideas with colleagues from across the world.
I was also fortunate to attend the congress alongside my colleagues Noemi Zuccaro, Philippine Bruno, Sébastien Ibanez, and Engy Vigneron, which made the experience even more enjoyable. Sharing the sessions, discussions, and discoveries together created many memorable moments and sparked new ideas for our work.
I am especially grateful for the opportunity to present my research during an oral presentation. Sharing my work with such an engaged audience and receiving valuable feedback was both rewarding and motivating.
A big thank you to the organizers, speakers, and participants for making this congress such a success.
I am leaving with new ideas, new connections, and renewed enthusiasm for my research. Looking forward to coming back next year!”
“Happy to have participated in EACR 2026, held in Budapest.
I was inspired by the great science and enjoyed the opportunity to connect with new peers in the cancer research field.
This conference gave me not only new ideas, but also a fresh perspective on the direction I would like to take in my scientific career path.
Thank you to the European Association for Cancer Research (EACR) for organizing such an amazing conference!”
“Humbled and honored to have been invited to participate in the European Association for Cancer Research (EACR) 2026 Congress as a poster presenter and travel grant recipient.
I am deeply grateful to everyone I had the opportunity to meet and connect with throughout the congress, as well as to the organizers for making this outstanding event possible.
It was an inspiring experience to learn from so many talented researchers and clinicians from around the world, including Carlota Castro-Espin.
I would also like to express my sincere thanks to CONFÍE Sinaloa for their financial support, and to all the incredible people around me who helped make my attendance possible.
Looking forward to staying connected and meeting again in the near future!”
“Exciting days at the Annual Congress of the European Association for Cancer Research (EACR) in Budapest.
I was happy to attend this year’s EACR Congress and present a poster from my PhD project on the lipogenic enzyme SCD1, its role in colorectal cancer, and the involvement of the gut microbiome.
Beyond the science, conferences are always more enjoyable when shared with great colleagues and friends.
A special thanks to Max Umbach and Andrea Estrella Arias Díaz for making the time in Budapest even more memorable.
I am also deeply grateful to have been selected as one of this year’s EACR Travel Grant recipients.”
“Congratulations to Paula Hoffmanová, Lukáš Peřina, and Jaroslava Šafářová on presenting their first scientific posters at the European Association for Cancer Research (EACR) Congress 2026 in Budapest.
For every young scientist, the first international conference presentation is an important milestone and a valuable opportunity to discuss research with colleagues from around the world.
Well done, and thank you for representing the Karel Soucek Lab, the Institute of Biophysics of the Czech Academy of Sciences, Masaryk University, and St. Anne’s University Hospital Brno so well.
We look forward to your next achievements.”
“Thrilled to be here at the European Association for Cancer Research (EACR) Congress 2026 in Budapest.
What an incredible conference.
I am grateful for the opportunity to present our recent work on leveraging chemotherapy-induced alterations in the tumor microenvironment to sensitize high-grade serous ovarian tumors to IAP antagonists.
A highlight was sharing this experience with my colleagues Francesca Dyson and Cedric Moser, and reconnecting with long-term colleagues and friends from across the field, including Rita Pinto.
These moments remind me why scientific conferences remain so valuable — the science, yes, but above all, the people behind it.
Already looking forward to what comes next.”
Stay informed with more articles like this on OncoDaily.
Written by Nare Hovhannisyan,MD